Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lamisil® (terbinafine) – New contraindication
August 23, 2016 – The FDA approved a new Contraindication for Lamisil (terbinafine) oral tablets regarding use in patients with chronic or active liver disease.
